32 completed. 32 Phase 3, 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 32 | Completed 32 |
| Phase 2 | 5 | Completed 5 |
Follow Menopause: new trials by email Literature Review of Menopause trials Research Report on Menopause
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Vaginal Health Trial Vagifem, Replens, Placebo tablet - Atrophy of Vagina, Menopause | Phase 3 | Completed | Fred Hutchinson Cancer Center | 302 | 2016-04-01 | 2018-07-12 |
| Effect of Oral Estradiol and Progesterone Therapy on Vaginal Cytokines in Postmenopausal Women oral estradiol 1.0 mg, oral progesterone 100 mg - Menopause | Phase 3 | Completed | Intira Sriprasert | 20 | 2015-12-01 | 2020-03-19 |
| Estradiol Vaginal Softgel Capsules in Treating Symptoms of Vulvar and Vaginal Atrophy in Postmenopausal Women Estradiol, Placebo - Vulvovaginal Atrophy, Menopause | Phase 3 | Completed | TherapeuticsMD | 764 | 2014-09-01 | 2017-05-25 |
| A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms Estradiol, Progesterone, Placebo - Menopause | Phase 3 | Completed | TherapeuticsMD | 1845 | 2013-08-05 | 2019-05-06 |
| Qing'E Formula Therapy on Menopausal Symptoms Qing'E pills, Placebo - Menopause | Phase 2 / Phase 3 | Completed | Shanghai University of Traditional Chinese Medicine | 240 | 2013-03-01 | 2019-04-05 |
| Therapy to Prevent Sexual Pain in Breast Cancer Survivors Topical liquid lidocaine, Topical saline - Vulvodynia, Dyspareunia | Phase 3 | Completed | OHSU Knight Cancer Institute | 50 | 2011-12-01 | 2017-04-14 |
| Perimenopausal Estrogen Replacement Therapy Study Estradiol, Placebo - Perimenopause, Menopause | Phase 2 / Phase 3 | Completed | University of North Carolina, Chapel Hill | 172 | 2010-10-01 | 2017-08-22 |
| Study to Assess Efficacy of Risedronate in Preventing Bone Loss in Postmenopausal Women Treated for Breast Cancer Risedronate, Placebo - Breast Cancer, Menopause | Phase 3 | Completed | Hospices Civils de Lyon | 20 | 2009-11-01 | 2013-10-31 |
| Study Evaluating The Effects Of Bazedoxifene/Conjugated Estrogens On Endometrial Safety And Postmenopausal Osteoporosis bazedoxifene 20 mg/ conjugated estrogens 0.45 mg, bazedoxifene 20 mg/ conjugated estrogens 0.625 mg, bazedoxifene 20 mg - Menopause, Osteoporosis | Phase 3 | Completed | Pfizer | 1886 | 2009-01-01 | 2014-04-08 |
| Forteo for the Treatment of Unexplained Osteoporosis in Premenopausal Women Teriparatide (PTH 1-34) - Menopause, Fracture | Phase 2 / Phase 3 | Completed | Columbia University | 22 | 2008-08-20 | 2018-07-26 |
| Efficacy and Safety of Estradiol and Progesterone Microspheres for the Treatment of Climacteric Symptoms. Estradiol and Progesterone - Menopause | Phase 2 / Phase 3 | Completed | Centro A.F. de Estudios Tecnologicos, S.A. | 103 | 2007-04-01 | 2009-08-25 |
| Endometrial Safety of a Low Dose of VagifemĀ® in Postmenopausal Women With Atrophic Vaginitis estradiol, 10 mcg - Menopause, Postmenopausal Vaginal Atrophy | Phase 3 | Completed | Novo Nordisk A/S | 336 | 2007-01-01 | 2017-03-15 |
| A Clinical Trial to Evaluate the Safety and Efficacy of DR-2041(Synthetic Conjugated Estrogens, A) for Treatment of Vulvovaginal Atrophy DR-2041a, DR-2041b, Placebo - Menopause | Phase 3 | Completed | Duramed Research | 622 | 2006-08-01 | 2015-04-20 |
| Study of the Safety and Efficacy of Desvenlafaxine Succinate for Vasomotor Symptoms in Postmenopausal Women Desvenlafaxine succinate sustained-release (DVS SR) - Menopause, Vasomotor System | Phase 3 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 450 | 2006-06-01 | 2007-06-01 |
| Study Evaluating DVS-233 SR for Treatment of Vasomotor Symptoms Associated With Menopause DVS-233 - Menopause | Phase 3 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 465 | 2005-04-01 | 2007-06-01 |
| Vagifem Low Dose for Postmenopausal Atrophic Vaginitis Symptoms estradiol, 10 mcg - Menopause, Postmenopausal Vaginal Atrophy | Phase 3 | Completed | Novo Nordisk A/S | 309 | 2005-03-01 | 2017-02-08 |
| A Clinical Trial to Evaluate the Safety and Efficacy of Enjuvia 0.3 mg for the Treatment of Vulvovaginal Atrophy Synthetic Conjugated estrogens, B, Placebo - Menopause | Phase 3 | Completed | Duramed Research | 300 | 2004-11-01 | 2013-09-02 |
| Dose-Finding Safety and Efficacy Trial of Org50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (46101/P06459/MK-8265-012) esmirtazapine, Placebo - Menopause, Vasomotor Symptoms | Phase 3 | Completed | Merck Sharp & Dohme LLC | 943 | 2004-10-15 | 2019-04-02 |
| Dose-Finding Safety and Efficacy Trial of Org 50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (177001/P06472/MK-8265-013) Esmirtazapine, Placebo - Postmenopausal Symptoms, Menopause | Phase 3 | Completed | Merck Sharp & Dohme LLC | 946 | 2004-09-15 | 2019-04-02 |
| Comparison of the Efficacy and Tolerability of Black Cohosh Vs Tibolone in Patients With Menopausal Symptoms Black Cohosh (iCR) or tibolone - Menopause | Phase 3 | Completed | Schaper & Bruemmer GmbH & Co KG | 240 | 2004-09-01 | 2006-03-06 |
Showing 20 of 32. Sign in to see all of them.
Hot Flashes (6) · Osteoporosis (5) · Bone Diseases, Metabolic (4) · Dyspareunia (4) · Breast Neoplasms (2) · Blushing (1) · Cardiovascular Diseases (1) · Depression (1) · Diabetes Mellitus (1) · Fever (1) · Fractures, Bone (1) · Heart Diseases (1) · Hypercholesterolemia (1) · Hypertension (1) · Obesity (1)
Pathological Conditions, Signs and Symptoms (8) · Signs and Symptoms (8) · Metabolic Diseases (6) · Musculoskeletal Diseases (6) · Nutritional and Metabolic Diseases (6) · Bone Diseases (5) · Mental Disorders (5) · Female Urogenital Diseases (4) · Female Urogenital Diseases and Pregnancy Complications (4) · Genital Diseases (4) · Genital Diseases, Female (4) · Genital Diseases, Male (4) · Male Urogenital Diseases (4) · Sexual Dysfunction, Physiological (4) · Sexual Dysfunctions, Psychological (4)
Estradiol (11) · Progesterone (4) · Estrogens, Conjugated (USP) (2) · Medroxyprogesterone Acetate (2) · Mirtazapine (2) · Diet, Fat-Restricted (1) · Estrogens (1) · Gabapentin (1) · Genistein (1) · Klimadynon (1) · Norethindrone Acetate (1) · Parathyroid Hormone (1) · Prempro (1) · Progestins (1) · Risedronic Acid (1)
Novo Nordisk A/S (5) · Wyeth is now a wholly owned subsidiary of Pfizer (3) · Duramed Research (2) · Merck Sharp & Dohme LLC (2) · TherapeuticsMD (2) · Bayer (1) · Boehringer Ingelheim (1) · Centro A.F. de Estudios Tecnologicos, S.A. (1) · Columbia University (1) · Fred Hutchinson Cancer Center (1) · Hospices Civils de Lyon (1) · Intira Sriprasert (1) · Karolinska University Hospital (1) · Mahidol University (1) · National Heart, Lung, and Blood Institute (NHLBI) (1)
United States (13) · Finland (5) · France (4) · Sweden (4) · Belgium (3) · Canada (3) · Denmark (3) · Hungary (3) · Mexico (3) · Norway (3) · United Kingdom (3) · China (2) · Czechia (2) · Netherlands (2) · Poland (2)
Adi Cohen, MD (1) · Andrea Z LaCroix, PhD (1) · Caroline Mitchell, MD, MPH (1) · David F Archer, MD (1) · Debra Butt, MSc MD CCFP (1) · Elizabeth Shane, MD (1) · Francesco Squadrito, MD (1) · Karolina Kublickiene, MD PhD (1) · Katherine A Guthrie, PhD (1)
PMID 18165394, PMID 18978105, PMID 20859151, PMID 30712391, PMID 17453860, PMID 17487652, PMID 17577003, PMID 1791769, PMID 18053998, PMID 18178111, PMID 18202966, PMID 19252451, PMID 20888118, PMID 21824950, PMID 23635731, PMID 24438370, PMID 24807329, PMID 25835751, PMID 26215946, PMID 27187320, PMID 28355090, PMID 29322164, PMID 29554173, PMID 29738424, PMID 29889748, PMID 30238814, PMID 30586005, PMID 30601452, PMID 30994576, PMID 31364889, PMID 31688572, PMID 31838497, PMID 31913228, PMID 32706883, PMID 32740481, PMID 32932401, PMID 33038141, PMID 33110039, PMID 33288437, PMID 33367735, PMID 33675793, PMID 34054104, PMID 35213517, PMID 35353163, PMID 36374501, PMID 37402281, PMID 37619252, PMID 38979716
2004 (2), R01AR048932 (1), R01HL045167 (1), R01MH087619 (1)